Choose your country to see the products for your location

ME030 BWS/RSS

SALSA® MLPA® Probemix ME030 BWS/RSS detects copy number variations and methylation status of differentially methylated regions (DMRs) in the 11p15 region and on chromosome 7 associated with Beckwith-Wiedemann syndrome (BWS) and/or Russell-Silver syndrome (RSS).

Specifications

Contents: 47 MLPA probes, including 30 for the BWS/RSS 11p15 region. Of these probes, 5 provide information on the methylation status of the H19/IGF2:IG-DMR, 2 of the IGF2:alt-TSS-DMR, and 4 of the KCNQ1OT1:TSS-DMR. In addition, information on the methylation status of MEST:altTSS-DMR and GRB10:alt-TSS-DMR is provided by 2 probes per DMR.

Tissue: human genomic DNA.

Application: research on Beckwith-Wiedemann syndrome (BWS), and Russell-Silver syndrome (RSS).

For research use only (RUO). Not for use in diagnostics.

Some ME030 users prefer the C3 version over the D1 version. Both product versions are available. Please indicate the product version of your choice when ordering. If no product version is mentioned, the D1 version will be shipped. Information about the C3 version can be found in its product description.

General information

The SALSA MLPA Probemix ME030 BWS/RSS is a research use only (RUO) assay for the detection of aberrant methylation of one or more sequences of the following differentially methylated regions (DMRs): KCNQ1OT1:TSS-DMR (also called IC2), H19/IGF2:IG-DMR (also called IC1) in the 11p15 chromosomal region associated with Beckwith-Wiedemann syndrome (BWS) and Russell-Silver syndrome (RSS). This probemix also includes probes for the IGF2:alt-TSS-DMR in the 11p15 chromosomal region. Additionally, this assay can be used for the detection of aberrant methylation of one or more sequences of the MEST:alt-TSS-DMR and GRB10:alt-TSS-DMR on chromosome 7 associated with RSS. This probemix can also be used to detect deletions/duplications in the aforementioned chromosomal regions. For better coverage of chromosome 7 and chromosome 14, we recommend to use SALSA MLPA Probemix ME032 UPD7-UPD14.

Genomic imprinting is the monoallelic expression of genes, dependent on the parental origin of the chromosome. It plays a role in growth and development. Imprinting disorders originate from a disturbance in this monoallelic expression by disruption or epimutation of imprinted genes (Ishida et al. 2013).

BWS is a clinically heterogeneous overgrowth syndrome associated with an increased risk for embryonal tumour development. RSS is a genetically heterogeneous disorder involving both intrauterine and postnatal growth retardation. The incidence of both BWS and RSS is estimated to be approximately 1 in 10,000-15,000 newborns and around 85% of the cases are sporadic (Õunap 2016). These conditions are both caused by a genetic or epigenetic alteration within two domains of imprinted growth regulatory genes on chromosomal region 11p15, leading to deregulated expression of the imprinted genes within this region. Approximately 60-70% of the patients have imprinting abnormalities at one of two imprinted domains IC1 or IC2, and these changes are frequently mosaic (see Figure 1 for a scheme of the imprinted gene cluster). Other known causes of BWS and RSS are uniparental disomy (UPD), trisomy 11p15, mutations in the CDKN1C gene, as well as small deletions and translocations. About 10% of RSS cases are caused by maternal UPD for chromosome 7 (Õunap 2016).

This SALSA MLPA Probemix ME030 BWS/RSS is capable of rapidly detecting most causes of BWS and RSS, as both copy numbers and methylation status of the 11p15 region can be determined. This MS-MLPA assay for BWS/RSS can also be useful for screening of childhood cancers, in particular Wilms' tumour. A strong linkage between hypermethylation of the IC1 locus, but not IC2, has been described in these patients resulting in biallelic expression of the IGF2 gene (Maas et al. 2016).

Figure 1. Scheme of the imprinted gene cluster on chromosome 11p15.

More information is available at https://www.ncbi.nlm.nih.gov/books/NBK1394/ (BWS) and https://www.ncbi.nlm.nih.gov/books/NBK1324/ (RSS).

Regulatory status

SALSA MLPA Probemix ME030 BWS/RSS is for research use only (RUO) in all territories.

List prices

Product

Item no.
Description
Technology
Price
ME030-025R
SALSA MLPA Probemix ME030 BWS/RSS – 25 rxn
€ 286.00
ME030-050R
SALSA MLPA Probemix ME030 BWS/RSS – 50 rxn
€ 560.00
ME030-100R
SALSA MLPA Probemix ME030 BWS/RSS – 100 rxn
€ 1096.00

Required reagents

A general SALSA MLPA Reagent Kit and SALSA HhaI are required for MS-MLPA experiments (to be ordered separately).

Item no.
Description
Technology
Price
EK1-FAM
SALSA MLPA Reagent Kit – 100 rxn – FAM (6 vials)
€ 348.00
EK1-Cy5
SALSA MLPA Reagent Kit – 100 rxn – Cy5 (6 vials)
€ 348.00
EK5-FAM
SALSA MLPA Reagent Kit – 500 rxn – FAM (5×6 vials)
€ 1600.00
EK5-Cy5
SALSA MLPA Reagent Kit – 500 rxn – Cy5 (5×6 vials)
€ 1600.00
EK20-FAM
SALSA MLPA Reagent Kit – 2000 rxn – FAM (5×6 vials)
€ 6152.00
SMR50
SALSA HhaI – 115 μl
€ 46.00

Other products

These optional accessories can be ordered separately.

Item no.
Description
Technology
Price
PCR001-FAM
SALSA PCR Reagents – 100 rxn – FAM
€ 173.00
PCR003-FAM
SALSA PCR Reagents – 300 rxn – FAM
€ 474.00

Price details & ordering

The prices above are list prices for direct orders from MRC Holland. Contact us for a quote that takes discounts and additional costs (such as shipping costs) into account. Different prices apply for orders through one of our sales partners; contact your local supplier for a quote.

Positive samples

Inclusion of a positive sample is usually not required, but can be useful for the analysis of your experiments. MRC Holland has very limited access to positive samples and cannot supply such samples. We recommend using positive samples from your own collection. Alternatively, you can use positive samples from an online biorepository, such as the Coriell Institute.

We have no information about specific commercially available positive samples that can be used with this product.

Publications

Selected publications using ME030 BWS/RSS

  • Eggermann K et al. (2016). EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver-Russell and Beckwith-Wiedemann syndrome. Eur J Hum Genet. 24:1377-87.
  • Gede LB et al. (2016). Feasibility study on the use of methylation-specific MLPA for the 11p15 region on prenatal samples. Prenat Diagn. 36:100-3.
  • Passaretti F et al. (2022). Different Mechanisms Cause Hypomethylation of Both H19 and KCNQ1OT1 Imprinted Differentially Methylated Regions in Two Cases of Silver-Russell Syndrome Spectrum. Genes (Basel). 13:1875.
  • Valente FM et al. (2019). Transcription alterations of KCNQ1 associated with imprinted methylation defects in the Beckwith-Wiedemann locus. Genet Med. 21:1808-20.

References

  • Ishida M et al. (2013). The role of imprinted genes in humans. Mol Aspects Med. 34:826-40.
  • Maas SM et al. (2016). Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A. 170:2248-60.
  • Õunap K (2016). Silver-Russell Syndrome and Beckwith-Wiedemann Syndrome: Opposite Phenotypes with Heterogeneous Molecular Etiology. Mol Syndromol. 7:110-21.

Sign in

Don't have an account? Create one

Forgot password?

Select Your Country

Choose your country to see the products for your location